Melbourne, Australia:
The Oxford/AstraZeneca COVID-19 vaccine administration in Australia, second vaccination to be approved for use in Australia by the Therapeutic Goods Administration (TGA), willl begin on Friday, 5th March, 2021 from South Australia. The vaccine will be administered to frontline health staff in the regional town of Murray Bridge, east of Adelaide – therefore leading the nation’s AstraZeneca Covid-19 vaccine immunisation drive.
According to Prime Minister Morrison, 300,000 doses of the vaccine, which had arrived in Sydney earlier this week, have been ‘batch-tested’ and approved for use. The PM also added that 50 million doses of the AstraZeneca vaccine will be made in Melbourne, Australia in the near future to launch the “next very significant phase of the home-grown vaccination of Australians for Covid-19”.
“We took the decision to have the sovereign capability to do that because we did not want to be, over the course of our vaccination program in Australia, overly reliant or dependent on supply chains from somewhere else,” the Prime Minister said.
